Biology is
software.
We back the engineers writing the code of life.
We back the engineers writing the code of life.
We believe the coming revolution in genetics will be one of the most value-creating venture categories in the next decade.
Gene tech startups aim to cure many of the worst and most expensive diseases, improving happiness and reducing healthcare needs. Other gene tech startups will enable plants and microbes to produce new kinds of products while sustaining the natural environment.
Lexi Ventures provides seed funding for US-based companies building around DNA, RNA, Cells, 'Omics.
Immunotherapy
Engineering T-cells to eradicate solid tumors without viral vectors.
RNA Delivery
A programmable "postal service" for mRNA, targeting tissues with 99% accuracy.
Gene Editing
High-fidelity CRISPR tools designed for safer, rapid clinical translation.
Tools
The quality control layer for gene editing—quantifying safety and off-target effects.
Diagnostics
Rapid, life-saving pathogen diagnostics for newborns and critical care.
Industrial Bio
Biomining platform using microbes to harvest critical minerals from industrial brine.
Proteomics
Next-generation single-molecule protein sequencing to decode the proteome.
Computational Bio
AI simulation platform predicting clinical trial outcomes and metabolic pathways.
Therapeutics
Precision genetic medicines targeting rare and neglected pediatric diseases.
Consumer Bio
Bio-engineered consumer products, starting with the world's first active probiotic skincare.
Founder & Managing Partner
Before founding Lexi Ventures, Jonah held founder, executive, and engineering roles in 7 startups over 25 years. He achieved 2 IPOs, 16 granted patents and wrote 2 books. He has a lifelong interest in science, engineering, economics, philosophy, and innovation.